Le Lézard
Classified in: Business
Subject: STH

IIROC Trading Halt - NSE


VANCOUVER, BC, Dec. 2, 2022 /CNW/ - The following issues have been halted by IIROC:

Company: New Stratus Energy Inc.

TSX-Venture Symbol: NSE

All Issues: Yes

Reason: Pending News

Halt Time (ET): 12:34 

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


These press releases may also interest you

at 10:17
The life insurance comparison site QuickQuote.com recently published a guide to accidental death and dismemberment (AD&D) insurance. It revealed that some plans cost only $4 a month and provide $100,000 in coverage....

at 10:16
Quarterra Multifamily, a subsidiary of Lennar Corporation and a vertically integrated multifamily apartment builder, developer and property manager, today announced the continued growth and success of Quarterra Emblem Communities with the opening of...

at 10:15
For the fourth consecutive year, BMO has been recognized in the 2024 Report on Business, Women Lead Here list ? an annual benchmark recognizing Canadian businesses with the highest achievement for executive gender diversity.  In line with its...

at 10:15
Chartis, a comprehensive healthcare advisory firm, today announced that its line of business focused on helping medical staff services departments (MSSDs) transform to elevate performance will restore its former name?Greeley, A Chartis Company. It...

at 10:14
ElementalTV, an innovator of data-enriched CTV advertising audience solutions, has announced a strategic partnership with Spanglish Movies, a leader in content creation and publishing for the Hispanic market. Together, the companies have created...

at 10:10
Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology and immunology, released annual...



News published on and distributed by: